Wordt geladen...
Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS
In the 12-month phase 3 TRANSFORMS study, fingolimod showed greater efficacy than intramuscular interferon beta (IFNβ)-1a in patients with relapsing–remitting multiple sclerosis (RRMS). This study analyzed fingolimod efficacy compared with IFNβ-1a in patient subgroups from TRANSFORMS. Patients were...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3737385/ https://ncbi.nlm.nih.gov/pubmed/23632946 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-013-6932-0 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|